{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:39:54Z","timestamp":1791855594231,"version":"4.3.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>New antithrombotic drugs have been developed, new valve types have been designed and minimally invasive transcatheter techniques have emerged, making the choice of antithrombotic therapy after surgical or transcatheter heart valve repair and replacement increasingly complex. Moreover, due to a lack of large randomized controlled trials many recommendations for antithrombotic therapy are based on expert opinion, reflected by divergent recommendations in current guidelines. Therefore, decision-making in clinical practice regarding antithrombotic therapy for prosthetic heart valves is difficult, potentially resulting in sub-optimal patient treatment. This article compares the 2017 ESC\/EACTS and 2020 ACC\/AHA guidelines on the management of valvular heart disease and summarizes the available evidence. Finally, we established a convenient consensus on antithrombotic therapy after valve interventions based on over 800 annual cases of surgical and transcatheter heart valve repair and replacement and a multidisciplinary team discussion between the department of cardiovascular diseases and cardiac surgery of the University Hospitals Leuven, Belgium.<\/jats:p>","DOI":"10.3389\/fcvm.2021.702780","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:47:21Z","timestamp":1628149641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement"],"prefix":"10.3389","volume":"8","author":[{"given":"Andreas","family":"Verstraete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Herregods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verbrugghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lamberigts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanassche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Meyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Oosterlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Adriaenssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Van Hoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegmund","family":"Keuleers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandenbriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sinnaeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Meuris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1053\/j.semtcvs.2019.05.033","article-title":"Aortic valve surgery in nonelderly patients: insights gained from AVIATOR","volume":"31","author":"Lansac","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.athoracsur.2019.07.014","article-title":"Degenerative mitral valve repair restores life expectancy","volume":"109","author":"Watt","year":"2020","journal-title":"Ann Thorac Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/oxfordjournals.eurheartj.a059586","article-title":"Relative survival of patients after heart valve replacement","volume":"11","author":"Abdelnoor","year":"1990","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jacc.2019.04.053","article-title":"Loss in life expectancy after surgical aortic valve replacement: SWEDEHEART study","volume":"74","author":"Glaser","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1520-765X(01)90037-9","article-title":"Prosthetic valve thrombosis: predisposition and diagnosis","volume":"3","author":"Piper","year":"2001","journal-title":"Eur Hear J Suppl."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC \/ AHA guideline for the management of patients with valvular heart disease. A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehu365","article-title":"The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties","volume":"35","author":"Iung","year":"2014","journal-title":"Eur Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1093\/eurheartj\/ehx199","article-title":"Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation","volume":"38","author":"Korteland","year":"2017","journal-title":"Eur Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.2014.12679","article-title":"Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years","volume":"312","author":"Chiang","year":"2014","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.2015.3164","article-title":"Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years","volume":"313","author":"Chikwe","year":"2015","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ahj.2010.05.005","article-title":"LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the \u201cLOWERING-IT\u201d Trial","volume":"160","author":"Torella","year":"2010","journal-title":"Am Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11883-014-0448-7","article-title":"Role of novel anticoagulants for patients with mechanical heart valves","volume":"16","author":"Forsberg","year":"2014","journal-title":"Curr Atheroscler Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2018.03.535","article-title":"Anticoagulation and antiplatelet strategies after On-X mechanical aortic valve replacement","volume":"71","author":"Puskas","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0003-4975(01)02656-X","article-title":"International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?","volume":"72","author":"K\u00f6rtke","year":"2001","journal-title":"Ann Thorac Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/eurheartj\/ehu330","article-title":"Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants","volume":"36","author":"Koertke","year":"2015","journal-title":"Eur Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/icvts\/ivr088","article-title":"Long-term self-management of anticoagulation therapy after mechanical heart valve replacement in outside trial conditions","volume":"14","author":"Mair","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/0735-1097(94)90753-6","article-title":"Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease","volume":"23","author":"Hayashi","year":"1994","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0022-5223(95)70243-1","article-title":"Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials","volume":"110","author":"Pouleur","year":"1995","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-8703(95)90365-8","article-title":"Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis","volume":"130","author":"Cappelleri","year":"1995","journal-title":"Am Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0735-1097(99)00598-7","article-title":"Early and long-term (one-year) effects of the association of Aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical Prosthesis","volume":"35","author":"Laffort","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin\u2013oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch Intern Med."},{"key":"B26","unstructured":"A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban (PROACT Xa)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am College Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.CIR.0000137122.95108.52","article-title":"Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study","volume":"110","author":"Gherli","year":"2004","journal-title":"Circulation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0038-1676816","article-title":"Antiplatelet therapy versus anticoagulation after surgical bioprosthetic aortic valve replacement: a systematic review and meta-analysis","volume":"119","author":"An","year":"2019","journal-title":"Thromb Haemost."},{"key":"B31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00392-015-0919-z","article-title":"Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves","volume":"105","author":"Yadlapati","year":"2016","journal-title":"Clin Res Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.jacc.2017.10.039","article-title":"National trends and outcomes in isolated tricuspid valve surgery","volume":"70","author":"Zack","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejcts.2009.06.021","article-title":"Aortic valve repair leads to a low incidence of valve-related complications","volume":"37","author":"Aicher","year":"2010","journal-title":"Eur J Cardio-thoracic Surg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jocs.14032","article-title":"Aortic valve repair or replacement in patients with aortic regurgitation: a systematic review and meta-analysis","volume":"34","author":"Wong","year":"2019","journal-title":"J Card Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jtcvs.2015.12.036","article-title":"Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair","volume":"151","author":"Paparella","year":"2016","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11239-018-1724-0","article-title":"Antithrombotic therapy after mitral valve repair: VKA or aspirin?","volume":"46","author":"van der Wall","year":"2018","journal-title":"J Thromb Thrombolysis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11239-020-02046-2","article-title":"Rivaroxaban in patients undergoing surgical mitral valve repair","volume":"49","author":"Noohi","year":"2020","journal-title":"J Thromb Thrombolysis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1093\/eurheartj\/ehx390","article-title":"Thrombo-embolic prevention after transcatheter aortic valve implantation","volume":"38","author":"Vranckx","year":"2017","journal-title":"Eur Heart J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","article-title":"Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomi","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/heartjnl-2018-314313","article-title":"Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"105","author":"Nijenhuis","year":"2019","journal-title":"Heart."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR","volume":"13","author":"Kawashima","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B52","unstructured":"Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)"},{"key":"B53","unstructured":"Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis (ATLANTIS)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.jacc.2015.10.018","article-title":"Randomized comparison of percutaneous repair and surgery for mitral regurgitation 5-year results of EVEREST II","volume":"66","author":"Feldman","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/heartjnl-2016-309585","article-title":"Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis","volume":"103","author":"Grzymala-Lubanski","year":"2017","journal-title":"Heart."},{"key":"B57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial","volume":"42","author":"Guimar\u00e3es","year":"2019","journal-title":"Clin Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.rec.2017.11.020","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardio Thoracic Surg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.120.046534","article-title":"Risk\/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS","volume":"141","author":"Alexander","year":"2020","journal-title":"Circulation."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.702780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:47:26Z","timestamp":1628149646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.702780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":62,"alternative-id":["10.3389\/fcvm.2021.702780"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.702780","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"article-number":"702780"}}